Clinical Research Directory
Browse clinical research sites, groups, and studies.
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
Sponsor: Medicines360
Summary
ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterventional observational cohort study of nulliparous singleton pregnant women to evaluate biomarkers from blood and ocular imaging for prediction of pregnancy complications \[i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)\] and risk of adverse outcomes.
Official title: A Multi-Site, Prospective, Two-Part Longitudinal, Observational Cohort Study Of Pregnant Women To Evaluate Biomarkers For Prediction Of Pregnancy Complications
Key Details
Gender
FEMALE
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
5500
Start Date
2026-07-30
Completion Date
2028-12-01
Last Updated
2026-06-25
Healthy Volunteers
Yes
Interventions
None (this is an observational study with no intervention)
This is an observational study to evaluateing biomarkers from blood and ocular imaging for prediction of pregnancy complications and associated risks \[i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)\].